VIM and breast carcinoma: In a dynamic in vivo model of metastatic breast cancer, Gilles and colleagues found that tumor cells in vascular tumoral emboli all express Vimentin (a marker of mesenchymal cells), but macrometastases in the lung display heterogenous Vimentin expression, and thus resemble the primary tumor (Bonnomet et al., 2012).